Analysis

Pharma Technology Focus – Issue 63

Pharma Technology Focus – Issue 63

Pharma Technology Focus – Issue 62

Pharma Technology Focus – Issue 62

Zika virus: an unlikely new anti-cancer candidate

Zika virus: an unlikely new anti-cancer candidate

Closing the US pharmaceutical industry’s growing skills gap

Closing the US pharmaceutical industry’s growing skills gap

Counting the cost of failure in drug development

Counting the cost of failure in drug development

The gene-silencing approach to cutting cholesterol

The gene-silencing approach to cutting cholesterol

May's top stories: Thermo Fisher Scientific buys Patheon for $7.2bn, AstraZeneca to sell rights for Seloken

May's top stories: Thermo Fisher Scientific buys Patheon for $7.2bn, AstraZeneca to sell rights for Seloken

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Narrowing the hunt for nanoparticles

Narrowing the hunt for nanoparticles

Cancergraph: a desperately needed link between patient and clinical trial

Cancergraph: a desperately needed link between patient and clinical trial

Illuminating drug discovery by mapping all known drugs

Illuminating drug discovery by mapping all known drugs

Turning to turmeric: exciting drug candidate or another dead end?

Turning to turmeric: exciting drug candidate or another dead end?

BlueRock Therapeutics: Ontario’s home-grown stem cell contender

BlueRock Therapeutics: Ontario’s home-grown stem cell contender

Using shark antibodies to treat Alzheimer’s disease

Using shark antibodies to treat Alzheimer’s disease

Medicines Discovery Catapult: improving collaborative drug discovery in the UK

Medicines Discovery Catapult: improving collaborative drug discovery in the UK

Therapeutic orphans: child-friendly drugs and the quest for adherence

Therapeutic orphans: child-friendly drugs and the quest for adherence

BenevolentAI: using artificial intelligence to speed up drug discovery

BenevolentAI: using artificial intelligence to speed up drug discovery

The Hive: new incubator makes a beeline for non-traditional pharma companies

The Hive: new incubator makes a beeline for non-traditional pharma companies

Pharma Technology Focus – Issue 55

Pharma Technology Focus – Issue 55

After the cure: addressing side effects in childhood cancer patients

After the cure: addressing side effects in childhood cancer patients

Antibiotic resistance: the race for the prize

Antibiotic resistance: the race for the prize
cachename:Featurescachekey:rd-137342983_989685772_rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_-1939411708